Saurashtra Cement Limited (SAURASHCEM.NS)
INR 108.68
(-1.18%)
INR 108.68
(-1.18%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 1.55 Billion | 214.52 Million | -81.74 Million | 1.33 Billion | 625.94 Million |
| Net Income | 898.51 Million | -291.23 Million | 374.68 Million | 1.02 Billion | 565.05 Million |
| Depreciation & Amortization | 470.85 Million | 388.69 Million | 331.65 Million | 200.36 Million | 190.25 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | 10.97 Million | 28.87 Million |
| Change in working capital | 482.5 Million | 155.74 Million | -646.31 Million | 302.18 Million | -416.91 Million |
| Other non-cash items | -220.14 Million | -13.32 Million | -25.92 Million | -28.04 Million | 258.66 Million |
| Investing Cash Flow | -1.57 Billion | 324.49 Million | -298.63 Million | -1.2 Billion | -383.79 Million |
| Investments in PPE | -684.33 Million | -389.4 Million | -461.84 Million | -388.05 Million | -236.64 Million |
| Acquisitions | - | - | -553.57 Million | - | - |
| Investment purchases | - | - | - | -897.75 Million | -205.63 Million |
| Sales/Maturities of investments | - | 601.95 Million | 575.93 Million | - | - |
| Other Investing Activities | -887.05 Million | 713.9 Million | 716.78 Million | 12.73 Million | 4000.00 |
| Financing Cash Flow | 26.53 Million | -491.16 Million | 310.93 Million | -171.65 Million | -234.34 Million |
| Debt repayment | -212.35 Million | -401.08 Million | -442.4 Million | -73.05 Million | -20.36 Million |
| Dividends payments | -110.92 Million | - | -42.29 Million | -56.28 Million | -121.62 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 2.53 Million | 1.83 Million | 15.58 Million | 2.62 Million | - |
| Other Financing Activities | 90.16 Million | -358.65 Million | 454.32 Million | -83.02 Million | -25 Million |
| Accounts receivables | -103.19 Million | -188.96 Million | -130.53 Million | 52.95 Million | -181.3 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -823.04 Million | 56.67 Million | -582.21 Million | 436.83 Million | -212.42 Million |
| Other working capital | 37.33 Million | 75 Thousand | -23.84 Million | -34.43 Million | -23.19 Million |
| Cash at beginning of period | 80.05 Million | 32.2 Million | 101.64 Million | 83.8 Million | 76 Million |
| Cash at end of period | 86.25 Million | 80.05 Million | 32.2 Million | 41.27 Million | 83.8 Million |
| Capital Expenditure | -684.33 Million | -389.4 Million | -461.84 Million | -388.05 Million | -236.64 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 6.19 Million | 47.85 Million | -69.44 Million | -42.53 Million | 7.8 Million |
| Free Cash Flow | 866.71 Million | -174.88 Million | -543.58 Million | 950.53 Million | 389.29 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 98.61 Million | 898.51 Million | 310.79 Million | 125.67 Million | 7.31 Million | 122.16 Million |
| Depreciation & Amortization | - | 470.85 Million | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 482.5 Million | - | - | - | - |
| Other non-cash items | -98.61 Million | -220.14 Million | -310.79 Million | -125.67 Million | -7.31 Million | -122.16 Million |
| Investing Cash Flow | - | -1.57 Billion | - | - | - | - |
| Investments in PPE | - | -684.33 Million | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -887.05 Million | - | - | - | - |
| Financing Cash Flow | - | 26.53 Million | - | - | - | - |
| Debt repayment | - | -212.35 Million | - | - | - | - |
| Dividends payments | - | -110.92 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 2.53 Million | - | - | - | - |
| Other Financing Activities | - | 90.16 Million | - | - | - | - |
| Accounts receivables | - | -103.19 Million | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -823.04 Million | - | - | - | - |
| Other working capital | - | 37.33 Million | - | - | - | - |
| Cash at beginning of period | - | 80.05 Million | - | - | - | - |
| Cash at end of period | - | 86.25 Million | - | - | - | - |
| Capital Expenditure | - | -684.33 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 6.19 Million | - | - | - | - |
| Free Cash Flow | - | 866.71 Million | - | - | - | - |
301180
SRGXF
001322
PPL-PA
JBCHEPHARM
BASC